{"nctId":"NCT02919917","briefTitle":"Treatment of Post-SCI Hypotension","startDateStruct":{"date":"2017-06-01","type":"ACTUAL"},"conditions":["Spinal Cord Injury","Autonomic Dysreflexia","Orthostatic Hypotension","Baroreceptor Integrity","Sympathetic Integrity","Vagal Integrity","Hypotension","Cerebral Blood Flow","Blood Pressure","Venous Occlusion Plethysmography"],"count":66,"armGroups":[{"label":"Usual Care Group","type":"EXPERIMENTAL","interventionNames":["Drug: Midodrine Hydrochloride"]},{"label":"BP Threshold Treatment Group","type":"EXPERIMENTAL","interventionNames":["Drug: Midodrine Hydrochloride"]}],"interventions":[{"name":"Midodrine Hydrochloride","otherNames":["Midodrine"]},{"name":"Midodrine Hydrochloride","otherNames":["Midodrine"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Any level of injury;\n* Any AIS grade of SCI;\n* Non-ventilator dependent\n* Primarily wheelchair dependent for mobility;\n* Duration of injury \\< 1 year\n* Systolic BP less than 110 mmHg and/or diastolic BP less than 70 mmHg for males.\n* Systolic BP less than 100 mmHg and/or diastolic BP less than 70 mmHg for females\n* Primary Language is English.\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* Have insufficient mental capacity to independently provide informed consent\n* Have insufficient English speaking or reading ability to provide informed consent or complete assessments in English\n* Have contraindications to the use of midodrine hydrochloride\n* Are pregnant","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"89 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Affected Therapy Sessions","description":"Responses to the questions \"was the therapy session affected by low BP or concern for low BP development?\" between the usual care and BP threshold treatment groups. The percent of sessions with a \"yes\" response are reported.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.4","spread":null},{"groupId":"OG001","value":"10.9","spread":null}]}]}]},{"type":"PRIMARY","title":"Systolic Blood Pressure","description":"Systolic hypertension (\\>/= 140 mmHg)","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.8","spread":null},{"groupId":"OG001","value":"5.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Systolic Blood Pressure","description":"Systolic hypotension (males: \\< 110 mmHg; females: \\< 100 mmHg)","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39.7","spread":null},{"groupId":"OG001","value":"43.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Missed Therapy Sessions","description":"Percentages of missed therapy sessions, due to low BP or concern for low BP development, in the usual care and BP treatment groups","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58.60","spread":null},{"groupId":"OG001","value":"65.8","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":29},"commonTop":[]}}}